Emerging Infectious Disease Diagnostics Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Growth Opportunities are Expected to Drive the Emerging Infectious Disease Diagnostics Market’s CAGR Through 2034?
In recent times, the market size of emerging infectious disease diagnostics has seen significant growth. Projected to expand from $22.13 billion in 2024 to $24.34 billion in 2025, this equates to a compound annual growth rate (CAGR) of 10.0%. The critical growth factors during this period include the heightened demand for point-of-care diagnostics, higher occurrence of infectious diseases, escalated global population density, increased number of infectious diseases cases, and an upsurge in healthcare spending.
In the coming years, the market size of emerging infectious disease diagnostics is anticipated to experience robust growth. With a compound annual growth rate (CAGR) of 9.7%, it’s projected to reach $35.21 billion by 2029. Factors such as escalating occurrences of zoonotic diseases, substantial regulatory changes and support, the creation of universal vaccines, a concentrated focus on the one health approach, and increased governmental support and funding are driving this predicted growth. Key trends for the forecast period encompass advancements in technology, next-generation sequencing (NGS), isothermal amplification techniques, the rise of telemedicine and remote diagnostics, as well as environmental pathogen monitoring.
What Drivers Are Shaping the Growth of the Emerging Infectious Disease Diagnostics Market?
The acceleration in the occurrence of zoonotic diseases is likely to fuel the expansion of the emerging infectious disease diagnostics market in the future. Such diseases, caused by bacteria, viruses, parasites, or fungi, are infections transferable from animals to humans. The escalating number of zoonotic diseases mainly occurs because of amplified human-animal interactions, destruction of habitats, and international travel, all of which make the transmission of pathogens across species easier. Diagnostics for emerging infectious diseases play a crucial role in controlling zoonotic diseases by enabling early detection and precise identification of pathogens. This allows for immediate action, effective treatment, and improved control of disease outbreaks, leading to a reduction in the transmission from animals to humans. To illustrate, in February 2024, as per the 2022 Zoonotic Disease Report released by State of West Virginia, a US government administration, in the MMWR Year 2022, the Lyme disease reported cases soared to 2,449, a significant increase from 1,788 cases in 2021. Consequently, the escalating occurrence of zoonotic diseases is propelling the growth of the emerging infectious disease diagnostics market.
Get Your Free Sample of the Global Emerging Infectious Disease Diagnostics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20548&type=smp
What Are the Leading Industry Players Dominating the Emerging Infectious Disease Diagnostics Market?
Major companies operating in the emerging infectious disease diagnostics market are:
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers
What Are the Latest Trends Leading to Disruption in the Emerging Infectious Disease Diagnostics Market?
Significant players within the market for emerging infectious disease diagnostics are emphasizing technological innovation, like molecular diagnostic platforms, as a means to achieve an upper hand. The use of nucleic acid amplification techniques in these platforms allows for highly sensitive and specific detection of pathogens, contributing to precise diagnosis and timely detection. For instance, Becton Dickinson and Company, a medical equipment production firm from the US, launched the BD COR MX/PX System, which is a fully automated diagnostic platform with high-throughput capacity, in May 2022. This system enhances lab efficiency by automating the entirety of the molecular workflow, from processing samples to generating results. Its pioneer assay, the BD CTGCTV2, can identify three common non-viral STIs. With on-board reagent and sample capacity, the BD COR MX/PX System can process a maximum of 1,700 specimens, offering over seven hours of uninterrupted operation and delivering up to 1,000 results within a day, thus drastically decreasing manual intervention from lab technicians.
Get Instant Access to the Global Emerging Infectious Disease Diagnostics Market Report with Swift Delivery!
What Are the Strategic Segments Comprising the Emerging Infectious Disease Diagnostics Market and Their Growth Contributions?
The emerging infectious disease diagnostics market covered in this report is segmented –
1) By Infection Type: Viral, Bacterial, Fungal, Other Infections
2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies
4) By Application: Laboratory Testing, Point-of-Care Testing
5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users
Subsegments:
1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections
4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections
Which Regions Are Significant to the Growth of the Emerging Infectious Disease Diagnostics Market?
North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can We Define the Emerging Infectious Disease Diagnostics Market and Its Key Components?
Emerging infectious disease diagnostics refers to the advanced methods and tools used to detect new or re-emerging infectious diseases caused by pathogens such as viruses, bacteria, or parasites. These diagnostics leverage cutting-edge technologies such as molecular testing, genomics, and rapid assays to identify infections quickly and accurately, improving public health responses. They are crucial in monitoring and controlling outbreaks, as well as in developing targeted treatments and vaccines.
Browse Through More Similar Reports By The Business Research Company:
Point-of-Care Diagnostics Devices and Equipment Global Market Report 2025
Transplant Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Analysis of Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: